Lumexa Imaging Holdings, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing a return to net income for both the second quarter and the first half of the year compared to net losses in the same periods of 2025.

Key Highlights

  • Net income of $2,745 thousand for Q2 2026, compared to a net loss of $7,226 thousand in Q2 2025, according to the filing.
  • Total revenues of $264,162 thousand for Q2 2026, up from $251,402 thousand in Q2 2025.
  • Six-month net income of $4,462 thousand for the first half of 2026, versus a net loss of $14,913 thousand in the first half of 2025.
  • Total assets of $1,808,772 thousand as of June 30, 2026, compared to $1,764,557 thousand at December 31, 2025.
  • Accumulated deficit narrowed to $626,598 thousand at June 30, 2026, from $631,060 thousand at December 31, 2025.
  • 96,074,976 shares of common stock outstanding as of August 13, 2026.
  • Interest expense declined to $16,222 thousand in Q2 2026 from $30,097 thousand in Q2 2025.

Lumexa Imaging Returns to Profitability in First Half of 2026

According to the filing, Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI), a Delaware-incorporated company headquartered in Raleigh, North Carolina, reported total revenues of $264,162 thousand for the three months ended June 30, 2026, an increase from $251,402 thousand in the comparable prior-year quarter. For the six months ended June 30, 2026, total revenues reached $516,699 thousand, up from $496,403 thousand in the first half of 2025. Revenue components include net patient service revenue, related-party patient service revenue, management fee and other revenue, and related-party management fee and other revenue.

The company reported net income of $2,745 thousand for Q2 2026, compared to a net loss of $7,226 thousand in Q2 2025. The filing attributes part of the improvement in pre-tax results to a significant reduction in interest expense, which fell to $16,222 thousand in Q2 2026 from $30,097 thousand in Q2 2025. For the six-month period, interest expense totaled $32,553 thousand, down from $59,946 thousand in the prior-year period. The filing also notes a loss on extinguishment and modification of debt of $1,053 thousand in Q2 2026, with no comparable item in Q2 2025. Basic and diluted net income per common share were each $0.03 for Q2 2026 and $0.05 for the six-month period.

On the balance sheet, total assets were $1,808,772 thousand at June 30, 2026, including goodwill of $807,554 thousand and investments in unconsolidated affiliates of $423,331 thousand. Total liabilities stood at $1,193,711 thousand, with long-term debt, less current maturities, of $819,753 thousand. Total equity increased to $615,061 thousand from $586,123 thousand at December 31, 2025. The filing notes that the condensed consolidated balance sheets include assets of consolidated variable interest entities that can only be used to settle obligations of those VIEs, with creditors having no recourse to Lumexa Imaging Holdings, Inc.

What Was Disclosed

Lumexa Imaging Holdings filed its unaudited quarterly report covering Q2 and the first half of 2026, showing improved revenues, a shift from net losses to net income, reduced interest expense, and higher total assets and equity compared to year-end 2025.